The Efficacy of Anastrozole and Growth Hormone Therapy on Adult Height in Six Adolescent Males with Growth Hormone Deficiency or Idiopathic Short Stature

Table 2

Comparison of clinical characteristics of patients before and after Anastrozole treatment.

	Prior to Anastrozole	At NAH
Chronological age (yr)	13.9 ± 0.27 (range 13.7 to 14.4)	16.7 ± 0.8 (range 15.9 to 18.1)
Bone age (yr)	13.6 ± 0.6 (range 12.5 to 14)	15.5 ± 1.6 years (range 14 to 17)
Height (cm)	150.7 ± 4.5 (range 142.6 to 156.3)	170 ± 1.8 cm (range 168.5 to 173.4)
Height SDS	−1.55 ± 0.5 (range −0.8 to −2.3 SD)	−0.74 ± 0.2 (range −0.4 to – 1.1)
Tanner stage
Pubic hair	2–4	4-5
Genitalia	3–5	4-5
Testicle size (mL)	10–20	20–25
PAH (cm)	162.6 ± 5.9 (range 153.5 to 168.6)	N/A
MPTH (cm)	173.6 ± 7 (range 161.8 to 181.6)	173.6 ± 7 (range 161.8 to 181.6)